Novartis withdraws EU application for aliskiren/valsartan

The European Medicines Agency (EMA) said Novartis AG (NYSE:NVS; SIX:NOVN) withdrew an MAA for Rasival aliskiren/valsartan to treat hypertension. According to the agency, the pharma said it would not b...